Neurocrine Biosciences (NBIX) CSO Jude Onyia makes bona fide stock gift

Rhea-AI Filing Summary

NEUROCRINE BIOSCIENCES INC Chief Scientific Officer Jude Onyia reported a bona fide gift of 2,409 shares of common stock effective August 4, 2026. No value was received and it was not a market transaction. Following the gift, Onyia directly holds 20,996 shares of common stock.

Insider Trade Summary

Net Seller: 2,409 shares

Net Sell 1 txn

Insider Onyia Jude

Role Chief Scientific Officer

Type	Security	Shares	Price	Value
Gift	Common Stock F1	2,409	$0.00	$0.00

Holdings After Transaction: Common Stock — 20,996 shares (Direct)

Footnotes (1)

1. F1. This transaction represents a gift/charitable contribution effective August 4, 2026. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares.

Key Figures

Gifted Shares: 2,409 shares Post-transaction Holdings: 20,996 shares Reported Transaction Price: $0.00 per share +2 more

5 metrics

Gifted Shares 2,409 shares Bona fide gift of common stock effective August 4, 2026

Post-transaction Holdings 20,996 shares Shares of common stock directly held after the gift

Reported Transaction Price $0.00 per share No value received; not a market transaction

Gift Transactions Count 1 Single bona fide gift reported in this Form 4

Total Gifted Shares in Summary 2,409 shares GiftShares in transaction summary

Key Terms

bona fide gift, charitable contribution, beneficially owned

3 terms

bona fide gift financial

"Transaction code description indicates a bona fide gift disposition"

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

charitable contribution financial

"Footnote describes the transaction as a gift/charitable contribution"

beneficially owned financial

"Total number of shares beneficially owned following the gift"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/05/2026 - 05:36 PM Accepted by SEC EDGAR 08/05/2026 - 05:35 PM Learn about SEC filing dates

FAQ

What insider transaction did NBIX executive Jude Onyia report?

Jude Onyia, Chief Scientific Officer of NBIX, reported a bona fide gift of 2,409 shares of common stock effective August 4, 2026. The filing specifies it was a gift/charitable contribution, not a market transaction, and no value was received for the shares.

How many NBIX shares did Jude Onyia transfer and on what date?

Jude Onyia transferred 2,409 shares of NBIX common stock effective August 4, 2026. The transaction is characterized as a gift/charitable contribution, coded as a bona fide gift, and therefore carries a reported per-share price of $0.00 with no consideration received.

Was the NBIX transaction by Jude Onyia a sale on the open market?

No. The NBIX transaction by Jude Onyia was a bona fide gift, explicitly described as a gift/charitable contribution and not a market transaction. The footnote states no value was received for the gifted shares, distinguishing it from an open-market sale.

How many NBIX shares does Jude Onyia hold after the reported gift?

After the reported gift of 2,409 shares, Jude Onyia directly holds 20,996 shares of NBIX common stock. This post-transaction holding figure is disclosed in the Form 4 as the total number of shares beneficially owned following the gift transfer.

Did Jude Onyia receive any proceeds from the NBIX share transfer?

No. The filing notes that no value was received for the 2,409 gifted shares. The transaction is described as a gift/charitable contribution and specifically states it is not a market transaction, so there were no sale proceeds or consideration paid to Onyia.

Is the reported NBIX insider transaction under a Rule 10b5-1 trading plan?

The transaction is a bona fide gift, and the Form 4’s Rule 10b5-1 plan checkbox is not marked as an affirming trading plan. The footnote instead emphasizes the charitable nature of the transfer and that it was not a market transaction with no value received.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Onyia Jude

(Last) (First) (Middle)

6027 EDGEWOOD BEND CT.

(Street)

SAN DIEGO CALIFORNIA 92130

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NEUROCRINE BIOSCIENCES INC [ NBIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Scientific Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/04/2026		G(1)		2,409	D	$0	20,996	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction represents a gift/charitable contribution effective August 4, 2026. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares.

Remarks:

	/s/ Darin Lippoldt, Attorney-in-Fact	08/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)